Graves disease
Unusual problems in the management of hyperthyroid graves’ disease
... with Graves’ disease ...Grave’s disease compared MMI alone with MMI plus SSKI and MMI plus sodium ...improved Graves’ disease in the short term and did not lead to worsening ...
14
TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves’ disease and Graves’ orbitopathy
... Thyrotoxicosis is a well-established cause for high bone turnover osteoporosis and fragility fractures (12). Our study demonstrates lower bone mineral density at axial skeleton (spine and hip) in hyperthyroid ...
6
Association between age at diagnosis of Graves' disease and variants in genes involved in immune response.
... Graves’ disease (GD) is an autoimmune ...[7–8]. Disease phenotype is also different between patients with young age at GD diagnosis than in patients with older age at GD diagnosis ...
6
Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17.
... Insulin-like growth factor-1 receptor (IGF-1R) comprises two subunits, including a ligand binding domain on extra- cellular IGF-1Ra and a tyrosine phosphorylation site located on IGF-1Rb. IGF-1R is over-expressed by ...
9
The onset of systemic lupus erythematosus and thyroid dysfunction following graves’ disease - a case report and literature review
... Case Outline We report a case of a middle-aged woman who presented with systemic lupus erythe- matosus one year after being diagnosed with Graves’ disease. Prednisone and cyclophosphamide were administered ...
6
Neonates Born to Mothers with Graves’ Disease: 15 Year Experience of a Pediatric Endocrinology Department
... Between 2002 and 2017, there were 46 women with GD, who gave birth to 50 newborns (two cases of multiple pregnancies and two women were pregnant twice, making it a total of forty-eight pregnancies). Seven women had a ...
8
Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
... with Graves’ disease were enrolled in this retrospective case- control study at the Dalian Medical University affiliated hospital ...of Graves’ disease was in accordance with the Chinese ...
9
Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves' Disease
... A 42-year-old woman was referred to our clinic in 1998, be- cause of palpitations, hand tremor, and laboratory findings of hyperthyroidism (serum thyrotropin [thyroid-stimulating hor- mone, TSH] 0.05 µIU/mL [reference ...
4
Comprehensive genotyping in two homogeneous Graves' disease samples reveals major and novel HLA association alleles.
... In this study, we conducted a case-control association study (499 unrelated GD cases and 504 controls) by direct and comprehen- sive genotyping of 6 classical HLA loci (HLA-A, -B, -C, -DPB1, -DQB1 and -DRB1) to 4-digit ...
10
Chemokine (C-C motif) ligand 20, a potential biomarker for Graves' disease, is regulated by osteopontin.
... Interestingly, we found increased CCL20 expression in CD4+T cells purified from PBMCs treated with plasma from uGD patients, but not in cells treated with plasma from healthy donors (Fig[r] ...
8
Thyrotoxic Periodic Paralysis and Polymorphisms of the , , and Genes in Men with Graves Disease
... Recently, we evaluated the Arg16Gly polymorphism in the β2-adrenergic receptor ( ADRB2 ) gene and the number of CAG repeats in the androgen receptor ( AR ) gene in a small number of p[r] ...
5
Arq Bras Endocrinol Metab vol.57 número9
... equilibrium with DQB1*0201 and DQA1*0501, both of which are strongly associated with Graves’ disease (10-12). Finally, the DRB1*11/ DQB1*0301 geno- type is associated with aPOF (13,14). Thus, the HLA ...
5
Trends Psychiatry Psychother. vol.37 número2
... out Graves’ disease or chronic ...developed Graves’ disease in 2012, but was not taking the medications and had missed many appointments with psychiatrists and ...
4
Hipertiroidismo por doença de Graves durante a gestação.
... Purpose: to evaluate the influence of hyperthyroidism during pregnancy and the necessity of changing antithyroid drug dose in this period and after delivery. Methods: prospective evaluation of clinical and laboratorial ...
5
Reliability of the thyroid stimulating hormone receptor antibodies level determination in diagnosing and prognosing of immunogenic hyperthyroidism
... Background/Aim. Graves disease (GD) is defined as hy- perthyroidism with diffuse goiter caused by immunogenic ...the disease and the level at the end of medical therapy is associated with an ...
6
Rev. Bras. Reumatol. vol.51 número2 en v51n2a08
... Graves’ disease (GD) is an autoimmune disease caused by thyroid stimulating autoantibodies and is characterized by typical symptoms of hyperthyroidism (emotional lability, fatigue, tremor, ...
3
Arq Bras Endocrinol Metab vol.52 número7
... of Graves’ disease who developed an ag- gressive metastatic papillary thyroid carcinoma harbo- ring two different mutations (TSHR and N-RAS) but showing a “cold” nodule at ...
7
Apresentação atípica da oftalmopatia de Graves.
... with Graves’ ...The disease hasanacute andachronic stage, slowly progressing until it stabilizes, with rarecasesof spontaneous ...the disease is mainly treated with oral or intravenous ...
4
Tratamento do hipertireoidismo da Doença de Graves.
... Graves’ disease is the most frequent cause of hyperthyroidism and current treat- ments consist of antithyroid drugs (ATD), radioiodine (131I) and ...mild disease, small goiters, children, adolescents ...
10
Rev. Hosp. Clin. vol.54 número3
... with Graves’ disease who was not treated in time to prevent the severity of the situation and the fatal outcome, and for which the immediate cause of death seems to have been heart failure due to volume ...
4